Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

Abstract A subset of breast cancer patients benefits from preoperative bevacizumab and chemotherapy, but validated predictive biomarkers are lacking. Here, we aimed to evaluate tissue-based angiogenesis markers for potential predictive value regarding response to neoadjuvant bevacizumab treatment in...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, Oddbjørn Straume, Ingunn M. Stefansson, Elin Borgen, Øystein Garred, Bjørn Naume, Olav Engebraaten, Lars A. Akslen
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/c8a2b3892eea4e2a921d64ce837fe2d4
Tags: Add Tag
No Tags, Be the first to tag this record!